Abvc Biopharma (ABVC) Gross Margin Growth (3y) (2019 - 2025)
Abvc Biopharma (ABVC) Gross Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 14,836.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 589.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 53.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,244.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 569.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -16,326.00 |
| Sep 30, 2025 | -17,459.00 |
| Dec 31, 2024 | 8,969.00 |
| Sep 30, 2024 | 32.00 |
| Jun 30, 2024 | 189.00 |
| Mar 31, 2024 | -2,251.00 |
| Dec 31, 2023 | -642,678.00 |
| Sep 30, 2023 | -17,898.00 |
| Jun 30, 2023 | -119,278.00 |
| Mar 31, 2023 | -4,193.00 |
| Dec 31, 2022 | -4,257.00 |
| Sep 30, 2022 | -2,400.00 |
| Jun 30, 2022 | 429.00 |
| Mar 31, 2022 | -668.00 |
| Dec 31, 2021 | 603,192.00 |
| Sep 30, 2021 | 7,149.00 |
| Jun 30, 2021 | 6,976.00 |
| Mar 31, 2021 | 7,586.00 |
| Jun 30, 2020 | 19,813.00 |
| Dec 31, 2019 | -249.00 |